基本信息
浏览量:182
职业迁徙
个人简介
In addition to the research groups, I have established a GMP level production facility with four clear rooms engaged in the production of biological materials (including viral vectors, devices, therapeutic cells, e.g., mesenchymal stem cells and human embryonic stem cells) administered to humans in phase I/II studies. Jan 2015 – Dec 2016 I was also the associate editor of Hepatology – the leading journal in liver diseases.
Major achievements in the recent academic career: My achievements are concentrated in the field of translational medicine and include: 1. Development of hepatitis B and C viruses monoclonal antibodies that progressed into phase II clinical studies, and the development of the Trimera HBV and HCV mouse models to assess the anti-viral effects of these antibodies. 2. Understanding the molecular and cellular factors that play a role in the biological axis of liver inflammation à regeneration à cancer (hepatocellular cancer). 3. Development of novel gene therapy platforms, e.g., the usage of ultrafast infrared femtosecond laser for dermal, muscle and retinal naked DNA transfection.
Current research interest relevant to this program: Our group investigated the role of inflammatory factors contributing to liver regeneration upon infection. While investigating these factors along the years, we have learned that the IL6-gp130 pathway is pivotal for the regeneration of liver parenchyma. This understanding further engaged us in studies aimed at translating the knowledge generated to determine the role of IL6-gp130 in the regeneration and anti-apoptosis in other tissues. Our current data show that this pathway is involved in the protection and regeneration of the kidney, heart, bone marrow stem cells and the salivary gland. In the recent years, we have also been investigating the significance of microRNAs in the regulation of physiological and pathological human conditions by studying mouse models. These have revealed some astonishing results. One is the role of miR 122 in controlling lipid metabolism, influencing anemia development and encountering anti-tumor properties.
Translational research: Our researchers at the institute and I, in particular, are believers in translational investigation. During recent years, I have been involved in a number of programs and these include: 1. Development of a novel therapy for pancreatic cancer based on siRNA targeting K-Ras (I established a company around this technology called Silenseed); 2. Development of FIV as a novel lentiviral vector for gene therapy. 3. Identification of new therapeutic targets for liver cancer. 4. Development of novel imaging technologies for the identification of liver pathology, tools that were further used in our program on liver inflammation à regeneration à cancer (hepatocellular cancer).
Major achievements in the recent academic career: My achievements are concentrated in the field of translational medicine and include: 1. Development of hepatitis B and C viruses monoclonal antibodies that progressed into phase II clinical studies, and the development of the Trimera HBV and HCV mouse models to assess the anti-viral effects of these antibodies. 2. Understanding the molecular and cellular factors that play a role in the biological axis of liver inflammation à regeneration à cancer (hepatocellular cancer). 3. Development of novel gene therapy platforms, e.g., the usage of ultrafast infrared femtosecond laser for dermal, muscle and retinal naked DNA transfection.
Current research interest relevant to this program: Our group investigated the role of inflammatory factors contributing to liver regeneration upon infection. While investigating these factors along the years, we have learned that the IL6-gp130 pathway is pivotal for the regeneration of liver parenchyma. This understanding further engaged us in studies aimed at translating the knowledge generated to determine the role of IL6-gp130 in the regeneration and anti-apoptosis in other tissues. Our current data show that this pathway is involved in the protection and regeneration of the kidney, heart, bone marrow stem cells and the salivary gland. In the recent years, we have also been investigating the significance of microRNAs in the regulation of physiological and pathological human conditions by studying mouse models. These have revealed some astonishing results. One is the role of miR 122 in controlling lipid metabolism, influencing anemia development and encountering anti-tumor properties.
Translational research: Our researchers at the institute and I, in particular, are believers in translational investigation. During recent years, I have been involved in a number of programs and these include: 1. Development of a novel therapy for pancreatic cancer based on siRNA targeting K-Ras (I established a company around this technology called Silenseed); 2. Development of FIV as a novel lentiviral vector for gene therapy. 3. Identification of new therapeutic targets for liver cancer. 4. Development of novel imaging technologies for the identification of liver pathology, tools that were further used in our program on liver inflammation à regeneration à cancer (hepatocellular cancer).
研究兴趣
论文共 282 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
Shiri Klein,Michal Abraham,Baruch Bulvik, Elia Dery,Ido D. Weiss,Neta Barashi,Rinat Abramovitch,Hanna Wald, Yaniv Harel, Devorah Olam,Lola Weiss, Katia Beider,
crossref(2023)
crossref(2023)
Shiri Klein,Michal Abraham,Baruch Bulvik, Elia Dery,Ido D. Weiss,Neta Barashi,Rinat Abramovitch,Hanna Wald, Yaniv Harel, Devorah Olam,Lola Weiss, Katia Beider,
crossref(2023)
Mark Katzenellenbogen,Orit Pappo,Hila Barash, Naama Klopstock, Lina Mizrahi, Devorah Olam,Jasmine Jacob-Hirsch,Ninette Amariglio, Gidi Rechavi, Leslie Ann Mitchell, Ron Kohen,Eytan Domany,
crossref(2023)
Mark Katzenellenbogen,Orit Pappo,Hila Barash, Naama Klopstock, Lina Mizrahi, Devorah Olam,Jasmine Jacob-Hirsch,Ninette Amariglio, Gidi Rechavi, Leslie Ann Mitchell, Ron Kohen,Eytan Domany,
crossref(2023)
Zohar Shmuelian, Yehuda Warszawer, Omri Or, Sagit Arbel-Alon,Hilla Giladi,Meytal Avgil Tsadok, Roy Cohen,Galit Shefer,Dekel Shlomi,Moshe Hoshen,Antonello Maruotti,Giovanna Jona-Lasinio,
Journal of Medical Virologyno. 1 (2023)
Shiri Klein,Michal Abraham,Baruch Bulvik, Elia Dery,Ido D. Weiss,Neta Barashi,Rinat Abramovitch,Hanna Wald, Yaniv Harel, Devorah Olam,Lola Weiss, Katia Beider,
crossref(2023)
Katia Beider,Merav Darash-Yahana, Orly Blaier,Maya Koren-Michowitz,Michal Abraham,Hanna Wald,Ori Wald,Eithan Galun,Orly Eizenberg,Amnon Peled,Arnon Nagler
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn